Shattuck Labs inc. Share Price Today: Live Updates & Key Insights

Shattuck Labs inc. share price today is $6.3, up 1.97%. The stock opened at $6.1 against the previous close of $6.1, with an intraday high of $6.3 and low of $6.05.

Shattuck Labs inc. Share Price Chart

Shattuck Labs inc.

us-stock
To Invest in {{usstockname}}
us-stock

Shattuck Labs inc. Share Price Performance

$6.3 0.0197(1.97%) STTK at 23 Mar 2026 03:22 PM Biotechnology
Lowest Today 6.05
Highest Today 6.3
Today’s Open 6.1
Prev. Close 6.1
52 Week High 6.31
52 Week Low 0.69
Day’s Range: Low 6.05 High 6.3
52-Week Range: Low 0.69 High 6.31
1 day return -
1 Week return +3.25
1 month return +46.97
3 month return +96.66
6 month return +154.93
1 year return +399.59
3 year return +105.81
5 year return -81.28
10 year return -

Shattuck Labs inc. Institutional Holdings

Adage Capital Partners Gp LLC 8.81

Orbimed Advisors, LLC 8.81

Redmile Group, LLC 7.74

NEXTBio Capital Management LP 4.40

Prosight Management, LP 3.33

Vanguard Group Inc 3.32

T. Rowe Price Small-Cap Value 2.75

T. Rowe Price Small-Cap Stock 2.48

Vanguard Total Stock Mkt Idx Inv 2.22

Clark Estates Inc 2.06

683 Capital Management LLC 1.94

Pinnacle Associates Inc 1.89

Bank of America Corp 1.58

T. Rowe Price Instl Small-Cap Stock 1.36

abrdn Life Sciences Investors 0.97

Geode Capital Management, LLC 0.86

Vanguard Institutional Extnd Mkt Idx Tr 0.85

Aberdeen Group PLC 0.74

Takeda Pharmaceutical Co Ltd 0.72

T. Rowe Price U.S. SC Value Eq Tr-D 0.71

Marshall Wace Asset Management Ltd 0.68

Millennium Management LLC 0.67

Two Sigma Investments LLC 0.61

BlackRock Inc 0.57

FMR Inc 0.55

Fidelity Select Biotechnology 0.55

Renaissance Technologies Corp 0.48

Acadian Asset Management LLC 0.46

Fidelity Extended Market Index 0.41

SEI Tax-Managed Small/Mid Cap F (SIMT) 0.17

Blackrock Extended Mkt Fund CF 0.15

Fidelity Total Market Index 0.14

Extended Equity Market Fund K 0.13

Vanguard VIF Small Co Gr 0.11

Spartan Extended Market Index Pool F 0.11

T. Rowe Price Spectrum Mod Gr Allc 0.11

SEI Small Cap II A (SIIT) 0.11

Fidelity Series Total Market Index 0.11

NT Ext Equity Mkt Idx Fd - NL 0.09

NT Ext Equity Mkt Idx Fd - L 0.09

Shattuck Labs inc. Market Status

Strong Buy: 2

Buy: 0

Hold: 3

Sell: 0

Strong Sell: 0

Shattuck Labs inc. Fundamentals

Market Cap 445.13 M

PB Ratio 5.381

PE Ratio 0.0

Enterprise Value 367.70 M

Total Assets 91.03 M

Volume 733554

Shattuck Labs inc. Company Financials

Annual Revenue FY23:1333000 1.3M, FY22:652000 0.7M, FY21:30017000 30.0M, FY20:9934000 9.9M, FY19:9887000 9.9M

Annual Profit FY23:null 0.0M, FY22:652000 0.7M, FY21:30017000 30.0M, FY20:9934000 9.9M, FY19:9887000 9.9M

Annual Net worth FY23:-95022000 -95.0M, FY22:-100561000 -100.6M, FY21:-44349000 -44.3M, FY20:-35436000 -35.4M, FY19:-23883000 -23.9M

Quarterly Revenue Q3/2025:1000000 1.0M, Q2/2025:0 0.0M, Q1/2025:14492000 14.5M, Q3/2024:2997000 3.0M, Q2/2024:1609000 1.6M

Quarterly Profit Q3/2025:1000000 1.0M, Q2/2025:-929000 -0.9M, Q1/2025:-936000 -0.9M, Q3/2024:2997000 3.0M, Q2/2024:-17630000 -17.6M

Quarterly Net worth Q3/2025:-10056000 -10.1M, Q2/2025:-12458000 -12.5M, Q1/2025:-13702000 -13.7M, Q3/2024:-16675000 -16.7M, Q2/2024:-21552000 -21.6M

About Shattuck Labs inc. & investment objective

Company Information Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Organisation Biotechnology

Employees 40

Industry Biotechnology

CEO Dr. Taylor H. Schreiber M.D., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Shattuck Labs inc. FAQs

What is the share price of Shattuck Labs inc. today?

The current share price of Shattuck Labs inc. is $6.3.

Can I buy Shattuck Labs inc. shares in India?

Yes, Indian investors can buy Shattuck Labs inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Shattuck Labs inc. shares in India?

You can easily invest in Shattuck Labs inc. shares from India by:

Can I buy fractional shares of Shattuck Labs inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Shattuck Labs inc.?

Shattuck Labs inc. has a market cap of $445.13 M.

In which sector does Shattuck Labs inc. belong?

Shattuck Labs inc. operates in the Biotechnology sector.

What documents are required to invest in Shattuck Labs inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Shattuck Labs inc.?

The PE ratio of Shattuck Labs inc. is N/A and the PB ratio is 5.38.